Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View Item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Role of hypoxia-inducible factor (HIF)-1 alpha-versus HIF-2 alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway

Thumbnail
Publication Date
2006-06-15
ICR Author
Ashcroft, Margaret
Author
Carroll, VA
Ashcroft, M
Type
Journal Article
Metadata
Show full item record
Abstract
Overexpression of hypoxia-inducible factors (HIF), HIF-1 alpha and HIF-2 alpha, leads to the up-regulation of genes involved in proliferation, angiogenesis, and glucose metabolism and is associated with tumor progression in several cancers. However, the contribution of HIF-1 alpha versus HIF-2 alpha to vascular endothelial growth factor (VEGF) expression and other HIF-regulated target genes under different conditions is unclear. To address this, we used small interfering RNA (siRNA) techniques to knockdown HIF-1 alpha and/or HIF-2 alpha expression in response to hypoxia, insulin-like growth factor (IGF)-I, or renal carcinoma cells expressing constitutively high basal levels of HIF-1 alpha and/or HIF-2 alpha due to loss of von Hippel-Lindau (VHL) function. We found that HIF-1 alpha primarily regulates transcriptional activation of VEGF in response to hypoxia and IGF-I compared with HIF-2 alpha in MCF-7 cells. We also observed a reciprocal relationship between HIF-1 alpha and HIF-2a expression in hypoxia in these cells: HIF-2 alpha siRNA enhanced HIF-1 alpha-mediated VEGF expression in MCF-7 cells in response to hypoxia, which could be completely blocked by cotransfection with HIF-1 alpha siRNA. In contrast, in renal carcinoma cells that constitutively express HIF-1 alpha and HIF-2 alpha due to loss of VHL function, we found that high basal VEGF, glucose transporter-1, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 expression was predominantly dependent on HIF-2 alpha. Finally, we showed that a newly identified small-molecule inhibitor of HIF-1, NSC-134754, is also able to significantly decrease HIF-2 alpha protein expression and HIF-2 alpha-regulated VEGF levels in renal carcinoma cells. Our data have important implications for how we target the HIF pathway therapeutically.
URL
https://repository.icr.ac.uk/handle/internal/2524
Collections
  • Other ICR Research
Version of record
10.1158/0008-5472.CAN-05-2519
Language
English
License start date
2006-06-15
Citation
CANCER RESEARCH, 2006, 66 pp. 6264 - 6270
Publisher
AMER ASSOC CANCER RESEARCH

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.